Treatement Options Study Group (n=40) Min- Max
None- observation (n,%) LMWH Hydroxychloroquine (n,%) Hydroxychloroquine +azithromycin (n,%) Hydroxychloroquine+azithromycin +oseltamivir (n,%) Hydroxychloroquine+lopinavir/ritonavir (n,%) 1 (2.5%) 40 (100%) 18 (45%) 7 (17.5%) 7 (17.5%) 4 (10%)
Hydroxychloroquine+azithromycin +lopinavir/ritonavir (n,%) Duration of hospitalization (days) 3 (7.5%) 5,4 ± 2,5
2-12